Unlocking Clinical Innovation: The Yuanliu Medical Innovation Research Initiative
In recent years, scientific research, industry, and innovation have become the nation's/High-frequency terms in industry discussions, while the translation of scientific research achievements serves as a link in the chainChinaa crucial component, it has also drawn significant attention from the industry.
According to relevant statistics, in 2021, China issued a total of 49 policies in the field of scientific and technological achievement transformation. The core content covered three key areas: “intellectual property, talent development, and research incentives,” directly addressing the critical pain points in industry development.
Furthermore, according to statistics from VCBeat’s Orange Fruit Bureau, China’s healthcare sector recorded 56 early-stage investment and financing transactions in the first quarter of 2022, with total funding exceeding RMB 3.5 billion—surpassing the full-year total for 2021 (when there were 59 early-stage deals amounting to RMB 2.5 billion). More than 100 investment institutions participated in these early-stage rounds. Capital inflow and enthusiasm for scientific research and innovation have far exceeded our expectations.
Both national policy guidance and capital flow trends indicate that the prospects for translating scientific research achievements into practical applications are immense. With the market launch of innovative medical products, even greater value will be unleashed, benefiting a larger number of patients.
Healthcare is distinct from other industries, characterized by high entry barriers, significant structural obstacles, and advanced technological requirements. Consequently, medical research and innovation primarily originate from hospitals, universities, and research institutes. As the core entity of healthcare delivery, hospitals place physicians at the frontline of patient care. Physicians not only participate in the entire continuum of disease prevention, diagnosis, treatment, and rehabilitation but also serve as end-users and beneficiaries of innovative outcomes. Possessing extensive insights into clinical needs, they hold the key to driving innovation and upgrading within the healthcare industry. Supported by favorable policies, capital investment, and advancements in digital technology, an increasing number of physicians are expanding their roles beyond clinical practice into scientific research, while actively engaging and collaborating with the industry.
To deepen engagement between physicians and the industry, and to foster the robust development of medical innovation and translation, VCBeat will launch—with the support of leading investors and enterprises including Legend Capital, Honghui Capital, Sequoia China, Matrix Partners China, Qiming Venture Partners, Bohe Angel, Sinovation Ventures, Becton Dickinson (BD), Boston Scientific, Ascletis Pharma, and ZKCX Star."Source & Stream: Medical Innovation Research Program", we hope to find like-minded medical professionals who are truly committed to scientific research innovation and industrial development, build a healthcare innovation system led by clinical experts, and ensure the continuous renewal of healthcare.
This survey targets all physicians. We welcome those who are interested in or already engaged in medical innovation to participate. The journey ahead is long; we invite you to walk it with us.
Survey Period: From today until September 30
Survey Subjects: Department Directors, Physicians, and Other Clinical Experts
Industrial Linkage: Priority access to VCBeat’s series of events on the translation of scientific research achievements, including summits/forums, closed-door seminars, case study solicitations, and project roadshows, to facilitate exchange and interaction between clinical practice and industry.
Image Building: Priority access to exclusive interviews on the commercialization of scientific research achievements, with dedicated reporting and promotion targeting the industry sector to build your professional image.
Ecological Empowerment: Establish communication channels between clinical needs and capital, as well as leading/innovative enterprises, to build a medical innovation ecosystem led by clinical experts and accelerate the positive linkage of resources within the ecosystem.
(Scan the QR code to participate in the survey)